Current Report Filing (8-k)
01 April 2019 - 11:10PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): April 1, 2019
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
001-38015
|
|
27-1865814
|
(State
or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (505) 438-2576
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[ ]
Item
2.02 Results of Operations and Financial Condition.
On
April 1, 2019, Sigma Labs, Inc. (the “Company”) issued a press release announcing the Company’s financial results
for the year ended December 31, 2018, and an update on recent developments. A copy of the press release is attached to this Report
as Exhibit 99.1 and is incorporated herein by reference.
The
information furnished under this Item 2.02, including the accompanying Exhibit 99.1, shall not be deemed to be “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to
the liability of such section, nor shall such information be deemed to be incorporated by reference in any previous or subsequent
filing by the company under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of
such filing, except as specifically stated in such filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
April 1, 2019
|
SIGMA LABS, INC.
|
|
|
|
|
By:
|
/s/
John Rice
|
|
Name:
|
John
Rice
|
|
Title:
|
President
and Chief Executive Officer
|
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Apr 2024 to May 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Sigma Labs Inc (NASDAQ): 0 recent articles
More Sigma Labs, Inc. News Articles